219 related articles for article (PubMed ID: 20886248)
1. Active Paget's disease of bone with normal biomarkers of bone metabolism: a case report and review of the literature.
Gkouva L; Andrikoula M; Kontogeorgakos V; Papachristou DJ; Tsatsoulis A
Clin Rheumatol; 2011 Jan; 30(1):139-44. PubMed ID: 20886248
[TBL] [Abstract][Full Text] [Related]
2. Paget's disease of the bone: a report of three cases.
Bhatt K; Balakrishnan C; Mangat G; Bajan K; Ashavaid T; Joshi VR
J Assoc Physicians India; 2006 Jul; 54():571-4. PubMed ID: 17089908
[TBL] [Abstract][Full Text] [Related]
3. Persistent effect of zoledronic acid in Paget's disease.
Tziomalos K; Florentin M; Krikis N; Perifanis V; Karagiannis A; Harsoulis F
Clin Exp Rheumatol; 2007; 25(3):464-6. PubMed ID: 17631747
[TBL] [Abstract][Full Text] [Related]
4. Two cases of monostotic Paget's disease: effects of bisphosphonate.
Hoshiro M; Harada T; Iwai H; Miyatake T; Nishimura A; Ohno Y; Aoki N
Endocr J; 2003 Aug; 50(4):385-92. PubMed ID: 14599111
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment of Paget's disease of bone : A clinical practice guideline.
Muschitz C; Feichtinger X; Haschka J; Kocijan R
Wien Med Wochenschr; 2017 Feb; 167(1-2):18-24. PubMed ID: 27600563
[TBL] [Abstract][Full Text] [Related]
6. Polyostotic Paget's disease.
Butt ST; Fatima S; Butt R; Nasir W; Jameel G; Irfan J
J Coll Physicians Surg Pak; 2012 Jul; 22(7):461-3. PubMed ID: 22747870
[TBL] [Abstract][Full Text] [Related]
7. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Abelson A
Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
[TBL] [Abstract][Full Text] [Related]
8. Bone turnover markers in Paget's disease of the bone: A Systematic review and meta-analysis.
Al Nofal AA; Altayar O; BenKhadra K; Qasim Agha OQ; Asi N; Nabhan M; Prokop LJ; Tebben P; Murad MH
Osteoporos Int; 2015 Jul; 26(7):1875-91. PubMed ID: 26037791
[TBL] [Abstract][Full Text] [Related]
9. Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate.
Hosking D; Lyles K; Brown JP; Fraser WD; Miller P; Curiel MD; Devogelaer JP; Hooper M; Su G; Zelenakas K; Pak J; Fashola T; Saidi Y; Eriksen EF; Reid IR
J Bone Miner Res; 2007 Jan; 22(1):142-8. PubMed ID: 17032148
[TBL] [Abstract][Full Text] [Related]
10. Management of Paget's Disease of the Calcaneum.
Humphrey J; Pervez A; Walker R; Abbasian A; Singh S
J Foot Ankle Surg; 2017; 56(2):401-403. PubMed ID: 28089128
[TBL] [Abstract][Full Text] [Related]
11. The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone.
Gennari L; Merlotti D; Mossetti G; Rendina D; De Paola V; Martini G; Nuti R
Mini Rev Med Chem; 2009 Aug; 9(9):1052-63. PubMed ID: 19689402
[TBL] [Abstract][Full Text] [Related]
12. Paget's disease of bone: analysis of 134 cases from an island in Southern Brazil: another cluster of Paget's disease of bone in South America.
Werner de Castro GR; Heiden GI; Zimmermann AF; Morato EF; Neves FS; Toscano MA; de Magalhães Souza Fialho SC; Pereira IA
Rheumatol Int; 2012 Mar; 32(3):627-31. PubMed ID: 21127877
[TBL] [Abstract][Full Text] [Related]
13. The use of zoledronic acid for Paget's disease of bone.
Maricic M
Curr Osteoporos Rep; 2006 Mar; 4(1):40-4. PubMed ID: 16527007
[TBL] [Abstract][Full Text] [Related]
14. [Paget's disease: case report].
Wegierska M; Ignaczak P; Zalewska J; Jeka S
Ann Acad Med Stetin; 2011; 57(3):64-9; discussion 69. PubMed ID: 23383549
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Bone Scintigraphy Results After Intravenous Zoledronate in Paget's Disease of Bone.
Reid IR; Maslowski K
Calcif Tissue Int; 2017 Jul; 101(1):43-49. PubMed ID: 28324123
[TBL] [Abstract][Full Text] [Related]
16. Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget's disease of bone.
Avramidis A; Polyzos SA; Moralidis E; Arsos G; Efstathiadou Z; Karakatsanis K; Grollios G; Kita M
J Bone Miner Metab; 2008; 26(6):635-41. PubMed ID: 18979164
[TBL] [Abstract][Full Text] [Related]
17. [Effect of a single dose of zoledronic acid in a case of Paget bone disease].
Saban M; Fidalgo S; Díaz CA; Lutfi RJ
Medicina (B Aires); 2010; 70(5):445-8. PubMed ID: 20920964
[TBL] [Abstract][Full Text] [Related]
18. A comparison of radiography and radioisotope scanning in the detection of Paget's disease and in the assessment of response to human calcitonin.
Lavender JP; Evans IM; Arnot R; Bowring S; Doyle FH; Joplin GF; MacIntyre I
Br J Radiol; 1977 Apr; 50(592):243-50. PubMed ID: 870130
[TBL] [Abstract][Full Text] [Related]
19. Zoledronic acid for Paget's disease of bone.
Maricic M
Drugs Today (Barc); 2007 Dec; 43(12):879-85. PubMed ID: 18174973
[TBL] [Abstract][Full Text] [Related]
20. Paget's disease with craniofacial and skeletal bone involvement.
Rai NP; Anekar J; Mustafa SM; Devang Divakar D
BMJ Case Rep; 2016 Sep; 2016():. PubMed ID: 27587747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
